Analysts count on revenue increase Carl Zeiss Meditec

Next Monday the German Carl Zeiss Meditec will publish its past quarters figures. Over the current book year the total revenue will be 1,42 billion euros (consensus estimates). This is quite more than 2017's revenue of 1,28 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2018

The analysts expect for 2018 a net profit of 162 million euros. For this year most of the analysts expect a profit per share of 1,81 euros. The price/earnings-ratio therefore equals 47,82.

For this year the analysts expect a dividend of 0,62 cents per share. Thus the dividend yield equals 0,72 percent. The average dividend yield of the pharmaceutical companies is a limited 0,5 percent.

Newest target prices around 80 euros

The most recent recommendations for the pharmaceutical company are from Hauck & Aufhauser, Nord Landesbank and Independent Research.

Based on the current number of shares Carl Zeiss Meditec's market capitalization equals 7,74 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite unstable. Since last May the stock is even 53 percent higher. This year the stock price moved between 56 and 89 euro. Since 2008 the stock price is almost 868 percent higher.

Historical stock prices Carl Zeiss Meditec

At 9.55 the stock trades 0,4 percent higher at 86,55 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.